Tumor Microenvironment Stress and Stress Adaptation Mechanisms

Authors

  • Qianqian Zhou School of Clinical Medicine, Wenzhou Medical University, Wenzhou, 325000, China
  • Jilong Wang School of Life Science, University of Science and Technology of China, Hefei, 230011, China

Keywords:

Tumor microenvironment stress, Stress adaptation, Hypoxia, Oxidative stress, Endoplasmic reticulum stress, Metabolic reprogramming, Mechanotransduction

Abstract

The tumor microenvironment (TME) constitutes a highly dynamic and interactive complex ecosystem, whose core components include tumor cells, stromal cells, immune cells, and an intricate network of signaling molecules. A prominent characteristic of this environment is the presence of multiple tumor-intrinsic stress responses, including hypoxia, oxidative stress, endoplasmic reticulum (ER) stress, metabolic stress, and mechanical stress. These stressors do not act in isolation but act synergistically to form a unique microenvironmental stress field, ultimately serving as a key biological engine that drives tumorigenesis, promotes disease progression, and induces therapeutic resistance. Emerging evidence highlights that targeted modulation of TME stress signaling pathways can not only suppress tumor growth but also remodel the immunosuppressive landscape, thereby augmenting anti-tumor immunity and achieving a synergistic “stress induction-immune activation” effect. This review provides a comprehensive synthesis of the molecular mechanisms underlying TME stress, adaptive strategies employed by tumor cells, and recent therapeutic advances centered on stress regulation. By integrating mechanistic insights with translational perspectives, this article aims to offer a foundational framework for developing novel combination therapies in oncology.

Downloads

Download data is not yet available.

References

Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J, et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Medicine. 2023, 12(10), 11149-11165. DOI: 10.1002/cam4.5698

Wu YZ, Su YH, Kuo CY. Stressing the regulatory role of long non-coding RNA in the cellular stress response during cancer progression and therapy. Biomedicines. 2022, 10(5), 1212. DOI: 10.3390/biomedicines10051212

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023, 41(3), 374-403. DOI: 10.1016/j.ccell.2023.02.016

Goliwas KF, Deshane JS, Elmets CA, Athar M. Moving immune therapy forward targeting TME. Physiological Reviews. 2021, 101(2), 417-425. DOI: 10.1152/physrev.00008.2020

Devi D, Sharma K, Khan T, Rani H, Rana R, Sharma H, et al. Hypoxia-driven metabolic and molecular reprogramming: from tumor microenvironment to therapeutic interventions. Pathology, Research and Practice. 2025, 276, 156271. DOI: 10.1016/j.prp.2025.156271

Liang X, Weng J, You Z, Wang Y, Wen J, Xia Z, et al. Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. Molecular Cancer. 2025, 24(1), 219. DOI: 10.1186/s12943-025-02375-x

Kalli M, Stylianopoulos T. Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment. APL Bioengineering. 2024, 8(1), 011501. DOI: 10.1063/5.0183302

Wang DW. Analysis on endoplasmic reticulum stress in the cancer cells. Theoretical and Natural Science. 2023, 22(1), 17-24. DOI: 10.54254/2753-8818/22/20230912

Liang XH, Chen XY, Yan Y, Cheng AY, Lin JY, Jiang YX, et al. Targeting metabolism to enhance immunotherapy within tumor microenvironment. Acta Pharmacologica Sinica. 2024, 45(10), 2011-2022. DOI: 10.1038/s41401-024-01304-w

Shah DD, Chorawala MR, Raghani NR, Patel R, Fareed M, Kashid VA, et al. Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies. Medical Oncology. 2025, 42(4), 117. DOI: 10.1007/s12032-025-02641-4

Li Y, Zhao L, Li XF. Hypoxia and the tumor microenvironment. Technology in Cancer Research & Treatment. 2021, 20, 15330338211036304. DOI: 10.1177/15330338211036304

Grasmann G, Mondal A, Leithner K. Flexibility and adaptation of cancer cells in a heterogenous metabolic microenvironment. International Journal of Molecular Sciences. 2021, 22(3), 1476. DOI: 10.3390/ijms22031476

Attique I, Haider Z, Khan M, Hassan S, Soliman MM, Ibrahim WN, et al. Reactive oxygen species: from tumorigenesis to therapeutic strategies in cancer. Cancer Medicine. 2025, 14(10), e70947. DOI: 10.1002/cam4.70947

Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. International Journal of Molecular Sciences. 2020, 21(21), 8363. DOI: 10.3390/ijms21218363

Salavati H, Debbaut C, Pullens P, Ceelen W. Interstitial fluid pressure as an emerging biomarker in solid tumors. Biochimica et Biophysica Acta. Reviews on Cancer. 2022, 1877(5), 188792. DOI: 10.1016/j.bbcan.2022.188792

Wang L, Zhang L, Zhang Z, Wu P, Zhang Y, Chen X. Advances in targeting tumor microenvironment for immunotherapy. Frontiers in Immunology. 2024, 15, 1472772. DOI: 10.3389/fimmu.2024.1472772

Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy. 2023, 8(1), 70. DOI: 10.1038/s41392-023-01332-8

Sun Y, Chen W, Torphy RJ, Yao S, Zhu G, Lin R, et al. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Science Translational Medicine. 2021, 13(604), eabc8922. DOI: 10.1126/scitranslmed.abc8922

Singleton DC, Macann A, Wilson WR. Therapeutic targeting of the hypoxic tumour microenvironment. Nature Reviews. Clinical Oncology. 2021, 18(12), 751-772. DOI: 10.1038/s41571-021-00539-4

Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nature Reviews. Cancer. 2014, 14(6), 430-9. DOI: 10.1038/nrc3726

Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. Journal of Cellular and Molecular Medicine. 2013, 17(1), 30-54. DOI: 10.1111/jcmm.12004

De Miguel MP, Alcaina Y, de la Maza DS, Lopez-Iglesias P. Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency. Current Molecular Medicine. 2015, 15(4), 343-59. DOI: 10.2174/1566524015666150505160406

Shi R, Liao C, Zhang Q. Hypoxia-driven effects in cancer: characterization, mechanisms, and therapeutic implications. Cells. 2021, 10(3), 678. DOI: 10.3390/cells10030678

Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA. Hypoxic regulation of metastasis via hypoxia-inducible factors. Current Molecular Medicine. 2008, 8(1), 60-7. DOI: 10.2174/156652408783565568

Chang J, Erler J. Hypoxia-mediated metastasis. Advances in Experimental Medicine and Biology. 2014, 772, 55-81. DOI: 10.1007/978-1-4614-5915-6_3

Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: The metabolic requirements of cell proliferation. Science. 2009, 324(5930), 1029-33. DOI: 10.1126/science.1160809

Keating ST, El-Osta A. Metaboloepigenetics in cancer, immunity and cardiovascular disease. Cardiovascular Research. 2023, 119(2), 357-370. DOI: 10.1093/cvr/cvac058

Adighibe O, Leek RD, Fernandez-Mercado M, Hu J, Snell C, Gatter KC, et al. Why some tumours trigger neovascularisation and others don’t: the story thus far. Chinese Journal of Cancer. 2016, 35, 18. DOI: 10.1186/s40880-016-0082-6

Yashiro N, Takai M, Yamamoto M, Kusumoto Y, Nagano S, Taniguchi A, et al. Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells. Advances in Biological Regulation. 2025, 96, 101068. DOI: 10.1016/j.jbior.2024.101068

Yang P, Zhang J. Indoleamine 2,3-dioxygenase (IDO) activity: a perspective biomarker for laboratory determination in tumor immunotherapy. Biomedicines. 2023, 11(7), 1988. DOI: 10.3390/biomedicines11071988

Karadima E, Chavakis T, Alexaki VI. Arginine metabolism in myeloid cells in health and disease. Seminars in Immunopatholog. 2025, 47(1), 11. DOI: 10.1007/s00281-025-01038-9

Ling ZN, Jiang YF, Ru JN, Lu JH, Ding B, Wu J. Amino acid metabolism in health and disease. Signal Transduction and Targeted Therapy. 2023, 8(1), 345. DOI: 10.1038/s41392-023-01569-3

Yao S, Chai H, Tao T, Zhang L, Yang X, Li X, et al. Role of lactate and lactate metabolism in liver diseases (review). International Journal of Molecular Medicine. 2024, 54(1), 59. DOI: 10.3892/ijmm.2024.5383

Rastogi S, Mishra SS, Arora MK, Kaithwas G, Banerjee S, Ravichandiran V, et al. Lactate acidosis and simultaneous recruitment of TGF-β leads to alter plasticity of hypoxic cancer cells in tumor microenvironment. Pharmacology & Therapeutics. 2023, 250, 108519. DOI: 10.1016/j.pharmthera.2023.108519

Liu Y, Si L, Jiang Y, Jiang S, Zhang X, Li S, et al. Design of pH-responsive nanomaterials based on the tumor microenvironment. International Journal of Nanomedicine. 2025, 20, 705-721. DOI: 10.2147/ijn.s504629

Dubuisson A, Mangelinck A, Knockaert S, Zichi A, Becht E, Philippon W, et al. Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancer. Frontiers in Immunology. 2025, 16, 1548509. DOI: 10.3389/fimmu.2025.1548509

Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. Experimental & Molecular Medicine. 2020, 52(2), 192-203. DOI: 10.1038/s12276-020-0384-2

Imai H. [biological significance of lipid hydroperoxide and its reducing enzyme, phospholipid hydroperoxide glutathione peroxidase, in mammalian cells]. Yakugaku Zasshi. 2004, 124(12), 937-57. DOI: 10.1248/yakushi.124.937

Ramalingam V, Rajaram R. A paradoxical role of reactive oxygen species in cancer signaling pathway: physiology and pathology. Process Biochemistry. 2021, 100, 69-81. DOI: 10.1016/j.procbio.2020.09.032

Zhao Y, Ye X, Xiong Z, Ihsan A, Ares I, Martínez M, et al. Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells. Metabolites. 2023, 13(7), 796. DOI: 10.3390/metabo13070796

Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, et al. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs “fertilizer”. Cell Cycle. 2011, 10(15), 2440-9. DOI: 10.4161/cc.10.15.16870

Hao S, Cai D, Gou S, Li Y, Liu L, Tang X, et al. Does each component of reactive oxygen species have a dual role in the tumor microenvironment? Current Medicinal Chemistry. 2024, 31(31), 4958-4986. DOI: 10.2174/0929867331666230719142202

Nakamura H, Takada K. Reactive oxygen species in cancer: current findings and future directions. Cancer Science. 2021, 112(10), 3945-3952. DOI: 10.1111/cas.15068

Tian Y, Tang L, Wang X, Ji Y, Tu Y. Nrf2 in human cancers: biological significance and therapeutic potential. American Journal of Cancer Research. 2024, 14(8), 3935-3961. DOI: 10.62347/lzvo6743

Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Archives of Toxicology. 2024, 98(5), 1323-1367. DOI: 10.1007/s00204-024-03696-4

Verma P, Rishi B, George NG, Kushwaha N, Dhandha H, Kaur M, et al. Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment. Pathology Oncology Research. 2023, 29, 1611415. DOI: 10.3389/pore.2023.1611415

Northey JJ, Przybyla L, Weaver VM. Tissue force programs cell fate and tumor aggression. Cancer Discovery. 2017, 7(11), 1224-1237. DOI: 10.1158/2159-8290.cd-16-0733

Yan H, Ramirez-Guerrero D, Lowengrub J, Wu M. Stress generation, relaxation and size control in confined tumor growth. PLoS Computational Biology. 2021, 17(12), e1009701. DOI: 10.1371/journal.pcbi.1009701

Purkayastha P, Jaiswal MK, Lele TP. Molecular cancer cell responses to solid compressive stress and interstitial fluid pressure. Cytoskeleton. 2021, 78(6), 312-322. DOI: 10.1002/cm.21680

Dwairy M, Reddy JN, Righetti R. Predicting stress and interstitial fluid pressure in tumors based on biphasic theory. Computers in Biology and Medicine. 2023, 167, 107651. DOI: 10.1016/j.compbiomed.2023.107651

Cuesta C, Alcon M, Zheng J, Prócel N, Cota RR, Fennema D, et al. RAS-PI3K pathway in CAFs shapes physicochemical properties of tumor ECM to impact tumor progression. Biorxiv-Cancer Biology. 2025. DOI: 10.1101/2025.01.20.633776

Peng Z, Ding YL, Zhang HY, Meng X, Huang YY, Zhang PF, et al. Mechanical force-mediated interactions between cancer cells and fibroblasts and their role in the progression of hepatocellular carcinoma. Journal of Cancer Metastasis and Treatment. 2024, 10, 4. DOI: 10.20517/2394-4722.2023.137

Ye M, Song Y, Pan S, Chu M, Wang ZW, Zhu X. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy. Pharmacology & Therapeutics. 2020, 215, 107633. DOI: 10.1016/j.pharmthera.2020.107633

Ansardamavandi A, Tafazzoli-Shadpour M. The functional cross talk between cancer cells and cancer associated fibroblasts from a cancer mechanics perspective. Biochimica et Biophysica Acta. Molecular Cell Research. 2021, 1868(11), 119103. DOI: 10.1016/j.bbamcr.2021.119103

Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduction and Targeted Therapy. 2021, 6(1), 153. DOI: 10.1038/s41392-021-00544-0

Heydari S, Tajik F, Safaei S, Kamani F, Karami B, Dorafshan S, et al. The association between tumor-stromal collagen features and the clinical outcomes of patients with breast cancer: a systematic review. Breast Cancer Research. 2025, 27(1), 69. DOI: 10.1186/s13058-025-02017-6

Li P, Zhou H, Yan R, Yan W, Yang L, Li T, et al. Aligned fibrous scaffolds promote directional migration of breast cancer cells via caveolin-1/YAP-mediated mechanosensing. Materials Today. Bio. 2024, 28, 101245. DOI: 10.1016/j.mtbio.2024.101245

Keller SB, Averkiou MA. The role of ultrasound in modulating interstitial fluid pressure in solid tumors for improved drug delivery. Bioconjugate Chemistry. 2022, 33(6), 1049-1056. DOI: 10.1021/acs.bioconjchem.1c00422

He YQ, Yang MX, Wang T, Xu LY, Ma ZH, Mu J, et al. Regulation of interstitial fluid pressure for improved intratumor drug permeability and nanozyme-enhanced chemocatalytic therapy. ACS Sustainable Chemistry & Engineering. 2022, 10(27), 8908-8918. DOI: 10.1021/acssuschemeng.2c02129

Li H, Jin W, Liu J, Zhou Y, Shan X, Zhang Y, et al. Optimizing mitochondria function in immune cells: implications for cancer immunotherapy. Trends in Cancer. 2025, 11(12), 1170-1184. DOI: 10.1016/j.trecan.2025.08.006

Lv Y, Lv Y, Wang Z, Yuan K, Zeng Y. Noncoding RNAs as sensors of tumor microenvironmental stress. Journal of Experimental & Clinical Cancer Research. 2022, 41(1), 224. DOI: 10.1186/s13046-022-02433-y

Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020, 38(2), 167-197. DOI: 10.1016/j.ccell.2020.06.001

Skrabalak I, Rajtak A, Malachowska B, Skrzypczak N, Skalina KA, Guha C, et al. Therapy resistance: modulating evolutionarily conserved heat shock protein machinery in cancer. Cancer Letters. 2025, 616, 217571. DOI: 10.1016/j.canlet.2025.217571

Hahne M, Schumann P, Mursell M, Strehl C, Hoff P, Buttgereit F, et al. Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: redundant HIF-dependent regulation of macrophage migration inhibitory factor. Microvascular Research. 2018, 116, 34-44. DOI: 10.1016/j.mvr.2017.09.004

Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America. 1995, 92(12), 5510-4. DOI: 10.1073/pnas.92.12.5510

Chowdhury M, Das PK. Hypoxia: intriguing feature in cancer cell biology. ChemMedChem. 2024, 19(9), e202300551. DOI: 10.1002/cmdc.202300551

Shi S, Ou X, Liu C, Wen H, Ke J. Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment. Frontiers in Immunology. 2025, 16, 1549276. DOI: 10.3389/fimmu.2025.1549276

Jin F, Zheng X, Yang Y, Yao G, Ye L, Doeppner TR, et al. Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFα and angiogenic VEGF. Aging-Us. 2019, 11(2), 328-349. DOI: 10.18632/aging.101726

Ha H, Choi Y, Kim NH, Kim J, Jang J, Niepa THR, et al. Lipid nanoparticle delivery system for normalization of tumor microenvironment and tumor vascular structure. Biomaterials Research. 2025, 29, 0144. DOI: 10.34133/bmr.0144

Guan Y, Weeder B, Patnaik A, Ornstein M, Garmezy B, Drakaki A, et al. Abstract A023: erythropoietin (EPO) is a pharmacodynamic biomarker for systemic HIF-2α inhibition that correlates with the clinical activity of casdatifan. Molecular Cancer Therapeutics. 2025, 24(10), A023-A023. DOI: 10.1158/1535-7163.targ-25-a023

Lin S, Chai Y, Zheng X, Xu X. The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. Molecular Biology Reports. 2023, 51(1), 14. DOI: 10.1007/s11033-023-08931-2

Zhang J, Yao M, Xia S, Zeng F, Liu Q. Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cellular & Molecular Biology Letters. 2025, 30(1), 2. DOI: 10.1186/s11658-024-00682-7

Juhász P, Méhes G. Tumor hypoxia: how conventional histology is reshaped in breast carcinoma. International Journal of Molecular Sciences. 2025, 26(9), 4423. DOI: 10.3390/ijms26094423

Zaarour RF, Ribeiro M, Azzarone B, Kapoor S, Chouaib S. Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance. Frontiers in Oncology. 2023, 13, 1222575. DOI: 10.3389/fonc.2023.1222575

Owida HA, Saleh RO, Mohammad SI, Vasudevan A, Roopashree R, Kashyap A, et al. Deciphering the role of circular RNAs in cancer progression under hypoxic conditions. Medical Oncology. 2025, 42(6), 191. DOI: 10.1007/s12032-025-02727-z

Capik O, Karatas OF. Pathways and outputs orchestrated in tumor microenvironment cells by hypoxia-induced tumor-derived exosomes in pan-cancer. Cellular Oncology. 2025, 48(3), 539-557. DOI: 10.1007/s13402-025-01042-z

Wu Z, Fang ZX, Hou YY, Wu BX, Deng Y, Wu HT, et al. Exosomes in metastasis of colorectal cancers: friends or foes?. World Journal of Gastrointestinal Oncology. 2023, 15(5), 731-756. DOI: 10.4251/wjgo.v15.i5.731

Wang CR, Xu S, Yang X. Hypoxia-driven changes in tumor microenvironment: insights into exosome-mediated cell interactions. International Journal of Nanomedicine. 2024, 19, 8211-8236. DOI: 10.2147/ijn.s479533

Abou Khouzam R, Janji B, Thiery J, Zaarour RF, Chamseddine AN, Mayr H, et al. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: impact on cancer immunotherapy. Seminars in Cancer Biology. 2023, 97, 104-123. DOI: 10.1016/j.semcancer.2023.11.008

Ciepła J, Smolarczyk R. Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies. Clinical and Experimental Medicine. 2024, 24(1), 235. DOI: 10.1007/s10238-024-01501-1

Garemilla SSS, Gampa SC, Garimella S. Role of the tumor microenvironment in cancer therapy: unveiling new targets to overcome drug resistance. Medical Oncology. 2025, 42(6), 202. DOI: 10.1007/s12032-025-02754-w

Alexandra Meyer, Luke Riggan. Mechanisms behind hypoxia-driven resistance to immunotherapy in the tumor microenvironment. Journal of Student Research. 2022, 11(3). DOI: 10.47611/jsrhs.v11i3.3837

Hanahan D, Michielin O, Pittet MJ. Convergent inducers and effectors of T cell paralysis in the tumour microenvironment. Nature Reviews Cancer. 2024, 25(1), 41-58. DOI: 10.1038/s41568-024-00761-z

Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sciences. 2021, 286, 120057. DOI: 10.1016/j.lfs.2021.120057

Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. Journal of Cellular Biochemistry. 2019, 120(3), 2782-2790. DOI: 10.1002/jcb.27681

Retamal MA, Salazar-Onfray F, González FE, Tittarelli A. Tumor hypoxia shapes natural killer cell anticancer activities. Journal of Molecular Medicine. 2025, 103(7), 755-777. DOI: 10.1007/s00109-025-02557-6.

Kim I, Choi S, Yoo S, Lee M, Kim IS. Cancer-associated fibroblasts in the hypoxic tumor microenvironment. Cancers. 2022, 14(14), 3321. DOI: 10.3390/cancers14143321

Dzwigonska M, Rosa P, Lipiec S, Obrebski T, Smyk G, Kaza B, et al. Hypoxic stress dysregulates functions of glioma-associated myeloid cells through epigenomic and transcriptional programs. Cell Reports. 2025, 44(9), 116222. DOI: 10.1016/j.celrep.2025.116222

Glorieux C, Liu SH, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nature Reviews. Drug Discovery. 2024, 23(8), 583-606. DOI: 10.1038/s41573-024-00979-4

Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nature Reviews. Cancer. 2022, 22(5), 280-297. DOI: 10.1038/s41568-021-00435-0

Aboelella NS, Brandle C, Kim T, Ding ZC, Zhou G. Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy. Cancers. 2021, 13(5), 986. DOI: 10.3390/cancers13050986

Wu CC, Mao YT, Wang X, Li P, Tang B. Deep-tissue fluorescence imaging study of reactive oxygen species in a tumor microenvironment. Analytical Chemistry. 2022, 94(1), 165-176. DOI: 10.1021/acs.analchem.1c03104

Jin P, Feng XD, Huang CS, Li J, Wang H, Wang XM, et al. Oxidative stress and cellular senescence: Roles in tumor progression and therapeutic opportunities. Medcomm-Oncology. 2024. DOI: 10.1002/mog2.70007

Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY, et al. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?. Journal of Biomedical Science. 2022, 29(1), 74. DOI: 10.1186/s12929-022-00859-2

D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular Cell Biology. 2007, 813-824. DOI: 10.1038/nrm2256

González-Pacheco FR, Caramelo C, Castilla MA, Deudero JJ, Arias J, Yagüe S, et al. Mechanism of vascular smooth muscle cells activation by hydrogen peroxide: Role of phospholipase C gamma. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2002, 17(3), 392-398. DOI: 10.1093/ndt/17.3.392

Kma L, Baruah TJ. The interplay of ROS and the PI3K/akt pathway in autophagy regulation. Biotechnol. Biotechnology and Applied Biochemistry. 2022, 69(1), 248-264. DOI: 10.1002/bab.2104

Koundouros N, Poulogiannis G. Phosphoinositide 3-kinase/akt signaling and redox metabolism in cancer - PubMed. Frontiers in Oncology. 2018, 8, 160. DOI: 10.3389/fonc.2018.00160

Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Seminars in Cell & Developmental Biology. 2018, 80, 50-64. DOI: 10.1016/j.semcdb.2017.05.023

Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Communication and Signaling: CCS. 2024, 22(1), 7. DOI: 10.1186/s12964-023-01398-5

Stieg DC, Wang Y, Liu LZ, Jiang BH. ROS and miRNA dysregulation in ovarian cancer development, angiogenesis and therapeutic resistance. International Journal of Molecular Sciences. 2022, 23(12), 6702. DOI: 10.3390/ijms23126702

Forman HJ, Zhang HQ, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine. 2009, 30(1-2), 1-12. DOI: 10.1016/j.mam.2008.08.006.

Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nature Medicine. 2005, 11(12), 1306-1313. DOI: 10.1038/nm1320

Teli A, Kshirsagar D, Doshi S, Dey T. Role-of-macrophages-in-oxidative-stress-induced-inflammatory-tumor-microenvironment. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2021, 1-16. DOI: 10.1007/978-981-15-4501-6_61-1

Wang MM, Xiao YP, Miao J, Zhang X, Liu M, Zhu LC, et al. Oxidative stress and inflammation drivers of tumorigenesis and therapeutic opportunities. Antioxidants. 2025, 14(6), 735. DOI: 10.3390/antiox14060735

Tunio SR, Siyal K, Menghwar K, Memon M, Tunio H, Memon MA. Potential interaction between inflammation and tumor microenvironment. International Journal of Agriculture and Biology. 2024, 33(330109), 1-13. DOI: 10.17957/ijab/15.2255

Ramundo V, Zanirato G, Palazzo ML, Riganti C, Aldieri E. APE-1/ref-1 inhibition blocks malignant pleural mesothelioma cell proliferation and migration: crosstalk between oxidative stress and epithelial mesenchymal transition (EMT) in driving carcinogenesis and metastasis. International Journal of Molecular Sciences. 2023, 24(16), 12570. DOI: 10.3390/ijms241612570

Zou WP. Abstract sy17-01: metabolic impact on immune cell subsets in the tumor microenvironment and its therapeutic relevance. Tumor Biology. 2018, 78(13). DOI: 10.1158/1538-7445.am2018-sy17-01

Weinberg F, Ramnath N, Nagrath D. Reactive oxygen species in the tumor microenvironment: an overview. Cancers. 2019, 11(8), 1191. DOI: 10.3390/cancers11081191

Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochimica Polonica. 2005, 52(2), 381-395. DOI: 10.18388/abp.2005_3451

Zhang DH, Lin LL, Jin H, Mao HJ, Wang LY, Ma WW, et al. Endoplasmic reticulum stress in lung cancer. Frontiers in Oncology. 2025, 15, 1550075. DOI: 10.3389/fonc.2025.1550075

Lu S, Zhou QM, Zhao RJ, Xie L, Cao WM, Feng YX. Unraveling UPR-mediated intercellular crosstalk: implications for immunotherapy resistance mechanisms. Cancer Letters. 2025, 617, 217613. DOI: 10.1016/j.canlet.2025.217613

Peng CS, Wang J, Wang S, Zhao Y, Wang HY, Wang YH, et al. Endoplasmic reticulum stress: triggers microenvironmental regulation and drives tumor evolution. Cancer Medicine. 2025, 14(5), e70684. DOI: 10.1002/cam4.70684

Zarrella S, Miranda MR, Covelli V, Restivo I, Novi S, Pepe G, et al. Endoplasmic reticulum stress and its role in metabolic reprogramming of cancer. Metabolites. 2025, 15(4), 221. DOI: 10.3390/metabo15040221

Wiseman RL, Mesgarzadeh JS, Hendershot LM. Reshaping endoplasmic reticulum quality control through the unfolded protein response. Molecular Cell. 2022, 82(8), 1477-1491. DOI: 10.1016/j.molcel.2022.03.025

Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR. Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity. Trends in Cancer. 2022, 8(11), 930-943. DOI: 10.1016/j.trecan.2022.06.006

Panda SK, Sanchez-Pajares IR, Rehman A, Del Vecchio V, Mele L, Chipurupalli S, et al. ER stress and/or ER-phagy in drug resistance? Three coincidences are proof. Cell Communication and Signaling: CCS. 2025, 23(1). DOI: 10.1186/s12964-025-02232-w

Zhang XH, Ma HJ, Gao Y, Liang YB, Du YT, Hao SL, et al. The tumor microenvironment: signal transduction. Biomolecules. 2024, 14(4), 438. DOI: 10.3390/biom14040438

Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nature Reviews. Cancer. 2021, 21(2), 71-88. DOI: 10.1038/s41568-020-00312-2.

Lindholm D, Korhonen L, Eriksson O, Kõks S. Recent insights into the role of unfolded protein response in ER stress in health and disease. Frontiers in Cell and Developmental Biology. 2017, 5, 48. DOI: 10.3389/fcell.2017.00048

Puente-Cobacho B, Varela-López A, Quiles JL, Vera-Ramirez L. Involvement of redox signalling in tumour cell dormancy and metastasis. Cancer Metastasis Reviews. 2023, 42(1), 49-85. DOI: 10.1007/s10555-022-10077-9

Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Molecular Biology of the Cell. 1999, 10(11), 3787-3799. DOI: 10.1091/mbc.10.11.3787

Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, et al. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes & Development. 2002, 16(4), 452-466. DOI: 10.1101/gad.964702

Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Molecular and Cellular Biology. 2003, 23(21), 7448-7459. DOI: 10.1128/mcb.23.21.7448-7459.2003

Gothland A, Jary A, Grange P, Leducq V, Beauvais-Remigereau L, Dupin N, et al. Harnessing redox disruption to treat human herpesvirus 8 (HHV-8) related malignancies. Antioxidants. 2022, 12(1), 84. DOI: 10.3390/antiox12010084

Zhang WL, Shi YD, Oyang LD, Cui SW, Li SZ, Li JY, et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell Death Discovery. 2024, 10(1), 343. DOI: 10.1038/s41420-024-02110-3

Vera-Ramirez L, Hunter KW. Tumor cell dormancy as an adaptive cell stress response mechanism. F1000Research. 2017, 6, 2134. DOI: 10.12688/f1000research.12174.1

Ochoa CD, Wu RF, Terada LS. ROS signaling and ER stress in cardiovascular disease. Molecular Aspects of Medicine. 2018, 63, 18-29. DOI: 10.1016/j.mam.2018.03.002

Hetz C, Papa FR. The unfolded protein response and cell fate control. Molecular Cell. 2018, 69(2), 169-181. DOI: 10.1016/j.molcel.2017.06.017

de Ridder I, Kerkhofs M, Lemos FO, Loncke J, Bultynck G, Parys JB. The ER-mitochondria interface, where Ca2+ and cell death meet. Cell Calcium. 2023, 112, 102743. DOI: 10.1016/j.ceca.2023.102743

Casas-Martinez JC, Samali A, McDonagh B. Redox regulation of UPR signalling and mitochondrial ER contact sites. Cellular and Molecular Life Sciences: CMLS. 2024, 81(1), 250. DOI: 10.1007/s00018-024-05286-0

Alicea Pauneto CDM, Riesenberg BP, Gandy EJ, Kennedy AS, Clutton GT, Hem JW, et al. Intra-tumoral hypoxia promotes CD8 T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4. Immunity. 2025, 58(10), 2489-2504.e8. DOI: 10.1016/j.immuni.2025.09.003

Dong H, Adams NM, Xu YC, Cao J, Allan DSJ, Carlyle JR, et al. The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-myc. Nature Immunology. 2019, 20(7), 865-878. DOI: 10.1038/s41590-019-0388-z

Jiang MS, Li X, Zhang JL, Lu YC, Shi YY, Zhu CQ, et al. Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under hypoxia to sensitize immunotherapy. ACS Nano. 2021, 15(9), 14522-14534. DOI: 10.1021/acsnano.1c04068

Mohamed E, Cao Y, Rodriguez PC. Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy. Cancer Immunology, Immunotherapy: CII. 2017, 66(8), 1069-1078. DOI: 10.1007/s00262-017-2019-6

Zhang C, Wang H, Li XY, Jiang YX, Sun GP, Yu HQ. Enhancing antitumor immunity: the role of immune checkpoint inhibitors, anti-angiogenic therapy, and macrophage reprogramming. Frontiers in Oncology. 2025, 15, 1526407. DOI: 10.3389/fonc.2025.1526407

Cognet G, Muir A. Identifying metabolic limitations in the tumor microenvironment. Science Advances. 2024, 10(40), eadq7305. DOI: 10.1126/sciadv.adq7305

Wang YP, Chen WJ, Wang ZD, Cai SW, Zhao XN, Jin JS, et al. Deciphering metabolic reprogramming of immune cells within the tumor microenvironment. Journal of Translational Medicine. 2025, 23(1), 1055. DOI: 10.1186/s12967-025-07069-y

Chuang HC, Chou CC, Kulp SK, Chen CS. AMPK as a potential anticancer target - friend or foe?. Current Pharmaceutical Design. 2014, 20(15), 2607-2618. DOI: 10.2174/13816128113199990485

Zhang MS, Zheng H, Zhu XQ, Liu SW, Jin H, Chen Y, et al. Synchronously evoking disulfidptosis and ferroptosis via systematical glucose deprivation targeting SLC7A11/GSH/GPX4 antioxidant axis. ACS Nano. 2025, 19(14), 14233-14248. DOI: 10.1021/acsnano.5c00730

Ji YK, Zhang Z, Zhao XR, Li ZY, Hu X, Zhang M, et al. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation. Cancer Letters. 2024, 589, 216833. DOI: 10.1016/j.canlet.2024.216833

Xia B, Qiu LQ, Yue J, Si JX, Zhang HF. The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: recent advances and future perspectives. Biochimica et Biophysica Acta. Reviews on Cancer. 2024, 1879(6), 189190. DOI: 10.1016/j.bbcan.2024.189190

Liu RD, Wang CD, Tao Z, Hu GY. Lipid metabolism reprogramming in cancer: insights into tumor cells and immune cells within the tumor microenvironment. Biomedicines. 2025, 13(8), 1895. DOI: 10.3390/biomedicines13081895

Jonker PB, Muir A. Metabolic ripple effects – deciphering how lipid metabolism in cancer interfaces with the tumor microenvironment. Disease Models & Mechanisms. 2024, 17(9), dmm050814. DOI: 10.1242/dmm.050814

Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. Journal of Hematology & Oncology. 2023, 16(1), 103. DOI: 10.1186/s13045-023-01498-2

Liu Y, Cao XT. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016, 30(5), 668-681. DOI: 10.1016/j.ccell.2016.09.011

Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Molecular Cell. 2020, 78(6), 1019-1033. DOI: 10.1016/j.molcel.2020.05.034

Wang HP, Franco F, Tsui YC, Xie X, Trefny MP, Zappasodi R, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nature Immunology. 2020, 21(3), 298-308. DOI: 10.1038/s41590-019-0589-5

Wu L, Zhang X, Zheng L, Zhao HK, Yan GF, Zhang Q, et al. RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis. Cancer Immunology Research. 2020, 8(5), 710-721. DOI: 10.1158/2326-6066.cir-19-0261

Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019, 569(7754), 73-78. DOI: 10.1038/s41586-019-1118-2

Xu SH, Chaudhary O, Rodríguez-Morales P, Sun XL, Chen D, Zappasodi R, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells in tumors. Immunity. 2021, 54(7), 1561-1577.e7. DOI: 10.1016/j.immuni.2021.05.003

Niavarani SR, Lawson C, Bakos O, Boudaud M, Batenchuk C, Rouleau S, et al. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period. BMC Cancer. 2019, 19(1), 823. DOI: 10.1186/s12885-019-6045-y

Gao FX, Shah R, Xin G, Wang RN. Metabolic dialogue shapes immune response in the tumor microenvironment. European Journal of Immunology. 2025, 55(4), e202451102. DOI: 10.1002/eji.202451102

Ruan LQ, Wang L. Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions. Frontiers in Oncology. 2025, 15, 1530541. DOI: 10.3389/fonc.2025.1530541

Li RY, Huang B, Tian H, Sun ZG. Immune evasion in esophageal squamous cell cancer: from the perspective of tumor microenvironment. Frontiers in Oncology. 2023, 12, 1096717. DOI: 10.3389/fonc.2022.1096717

Wu SJ, Kuang HX, Ke J, Pi MF, Yang DH. Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma. Frontiers in Oncology. 2021, 10, 591342. DOI: 10.3389/fonc.2020.591342

Wang J, He YL, Hu FM, Hu CC, Sun YJ, Yang K, et al. Metabolic reprogramming of immune cells in the tumor microenvironment. International Journal of Molecular Sciences. 2024, 25(22), 12223. DOI: 10.3390/ijms252212223

Jiang MQ, Wang YC, Zhao XY, Yu JM. From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape. Frontiers in Immunology. 2024, 15, 1492050. DOI: 10.3389/fimmu.2024.1492050

Zhang YJ, Zhang X, Meng YT, Xu XB, Zuo DY. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype. International Immunopharmacology. 2022, 110, 108994. DOI: 10.1016/j.intimp.2022.108994

Yang K, Wang XK, Song CH, He Z, Wang RX, Xu YR, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023, 13(6), 1774-1808. DOI:10.7150/thno.82920

Khalaf K, Hana D, Chou JT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Frontiers in Immunology. 2021, 12, 656364. DOI: 10.3389/fimmu.2021.656364

Angeli S, Neophytou C, Kalli M, Stylianopoulos T, Mpekris F. The mechanopathology of the tumor microenvironment: detection techniques, molecular mechanisms and therapeutic opportunities. Frontiers in Cell and Developmental Biology. 2025, 13, 1564626. DOI: 10.3389/fcell.2025.1564626

Kureel SK, Maroto R, Davis K, Sheetz M. Cellular mechanical memory: a potential tool for mesenchymal stem cell-based therapy. Stem Cell Research & Therapy. 2025, 16(1), 159. DOI: 10.1186/s13287-025-04249-x

Cambria E, Coughlin MF, Floryan MA, Offeddu GS, Shelton SE, Kamm RD. Linking cell mechanical memory and cancer metastasis. Nature Reviews. Cancer. 2024, 24(3), 216-228. DOI: 10.1038/s41568-023-00656-5

Vela-Alcántara AM, Santiago-García J, Barragán-Palacios M, León-Chacón A, Domínguez-Pantoja M, Barceinas-Dávila I, et al. Differential modulation of cell morphology, migration, and neuropilin-1 expression in cancer and non-cancer cell lines by substrate stiffness. Frontiers in Cell and Developmental Biology. DOI: 10.3389/fcell.2024.1352233

L. Zhang, Y. Xiao, M. Dong, M. Li, H. Chen, and J. Wang. Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and cytokeratin-19 in hepatocellular carcinoma. European Radiology. 2025, 35(8), 4722-4735. DOI: 10.1007/s00330-025-11375-w

Liu DX, Chen JJ, Zhang YF, Dai YM, Yao XZ. Magnetic resonance elastography-derived stiffness: potential imaging biomarker for differentiation of benign and malignant pancreatic masses. Abdominal Radiology. 2023, 48(8), 2604-2614. DOI: 10.1007/s00261-023-03956-4

Linke JA, Munn LL, Jain RK. Compressive stresses in cancer: characterization and implications for tumour progression and treatment. Nature Reviews. Cancer. 2024, 24(11), 768-791. DOI: 10.1038/s41568-024-00745-z

Nishi R, Oda Y, Morikura T, Miyata S. Effect of compressive stress in tumor microenvironment on malignant tumor spheroid invasion process. International Journal of Molecular Sciences. 2022, 23(13), 7091. DOI: 10.3390/ijms23137091

Teer L, Yaddanapudi K, Chen J. Biophysical control of the glioblastoma immunosuppressive microenvironment: opportunities for immunotherapy. Bioengineering. 2024, 11(1), 93. DOI: 10.3390/bioengineering11010093

Zhang YY, Zuo AN, Ba YH, Liu ST, Chen JQ, Yang SX, et al. Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation. Proceedings of the National Academy of Sciences of the United States of America. 2025, 122(21), e2423077122. DOI: 10.1073/pnas.2423077122

Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010, 141(1), 52-67. DOI: 10.1016/j.cell.2010.03.015

LaValley DJ, Zanotelli MR, Bordeleau F, Wang W, Schwager SC, Reinhart-King CA. Matrix stiffness enhances VEGFR-2 internalization, signaling, and proliferation in endothelial cells. Convergent Science Physical Oncology. 2017, 3, 044001. DOI: 10.1088/2057-1739/aa9263

Gao YW, Pan ZW, Li HQ, Wang F. Antitumor therapy targeting the tumor microenvironment. Journal of Oncology. 2023, 2023, 6886135. DOI: 10.1155/2023/6886135

Su XD, Xie Y, Zhang JW, Li MX, Zhang Q, Jin GS, et al. HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death & Disease. 2022, 13(10), 861. DOI: 10.1038/s41419-022-05304-8

Deeks ED. Belzutifan: first approval. Drugs. 2021, 81(16), 1921-1927. DOI: 10.1007/s40265-021-01606-x

Ajnai G, Cheng CC, Kan TC, Lu JW, Rahayu S, Chiu A, et al. Improving tirapazamine (TPZ) to target and eradicate hypoxia tumors by gold nanoparticle carriers. Pharmaceutics. 2022, 14(4), 847. DOI: 10.3390/pharmaceutics14040847

Zhang MY, Zhu J, Bao Y, Ao Q, Mao XL, Qiu ZZ, et al. Bevacizumab in ovarian cancer therapy: current advances, clinical challenges, and emerging strategies. Frontiers in Bioengineering and Biotechnology. 2025, 13, 1589841. DOI: 10.3389/fbioe.2025.1589841

He MY, Zhang MY, Xu T, Xue SJ, Li DZ, Zhao YN, et al. Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief. Journal of Controlled Release. 2024, 368, 233-250. DOI: 10.1016/j.jconrel.2024.02.030

Halpin-Veszeleiova K, Mallouh MP, Williamson LM, Apro AC, Botticello-Romero NR, Bahr C, et al. Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced immunosuppression. Journal of Clinical Investigation Insight. 2025, 10(6), e174675. DOI: 10.1172/jci.insight.174675

Budi HS, Izadi S, Timoshin A, Asl SH, Beyzai B, Ghaderpour A, et al. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine : Nanotechnology, Biology, and Medicine. 2021, 34, 102373. DOI: 10.1016/j.nano.2021.102373

Shi CR, Liu T, Guo ZD, Zhuang RQ, Zhang XZ, Chen XY. Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Letters. 2018, 18(11), 7330-7342. DOI: 10.1021/acs.nanolett.8b03568

Yu YF, Liu SZ, Yang LC, Song P, Liu ZH, Liu XY, et al. Roles of reactive oxygen species in inflammation and cancer. Medcomm. 2024, 5(4), e519. DOI: 10.1002/mco2.519

Yang L, Dong SM, Gai SL, Yang D, Ding H, Feng LL, et al. Deep insight of design, mechanism, and cancer theranostic strategy of nanozymes. Nano-micro Letters. 2023, 16(1), 28. DOI: 10.1007/s40820-023-01224-0

Li ZY, Ding BB, Li J, Chen H, Zhang JS, Tan J, et al. Multi-enzyme mimetic MoCu dual-atom nanozyme triggering oxidative stress cascade amplification for high-efficiency synergistic cancer therapy. Angewandte Chemie. 2025, 64(1), e202413661. DOI: 10.1002/anie.202413661

Zeng YH, Yang JF, Gu ZX, Liu HH, Cheng YP, Peng RY, et al. Tumor microenvironment-responsive lipid peroxidation amplifier: harnessing ferroptosis resistance to devastate the ferroptosis defense system. Analytical Chemistry. 2025, 97(13), 7278-7288. DOI: 10.1021/acs.analchem.4c06892

Chu X, Hou HY, Duan MD, Zhang YJ, Zhu YY, Liu Y, et al. Tumor microenvironment specific regulation ca-fe-nanospheres for ferroptosis-promoted domino synergistic therapy and tumor immune response. Small. 2024, 20(40), e2312141. DOI: 10.1002/smll.202312141

Wu YL, Wang G, Yang RX, Zhou DF, Chen QJ, Wu QY, et al. Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer. Neoplasia. 2025, 65, 101165. DOI: 10.1016/j.neo.2025.101165

Siwecka N, Rozpędek-Kamińska W, Wawrzynkiewicz A, Pytel D, Diehl JA, Majsterek I. The structure, activation and signaling of IRE1 and its role in determining cell fate. Biomedicines. 2021, 9(2), 156. DOI: 10.3390/biomedicines9020156

Asha K, Sharma-Walia N. Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics. Oncotarget. 2018, 9(61), 31920-31936. DOI: 10.18632/oncotarget.25886

Kawiak A, Kostecka A. Regulation of bcl-2 family proteins in estrogen receptor-positive breast cancer and their implications in endocrine therapy. Cancers. 2022, 14(2), 279. DOI: 10.3390/cancers14020279

Kurosu M, Mitachi K. DPAGT1-perspective as an anticancer drug target. Molecules. 2025, 30(20), 4049. DOI: 10.3390/molecules30204049

Lv GY, Sun SS, Li XY, Han RX, Liu SL, Lu M, et al. Cucurbitacin B suppresses glioblastoma via the STAT3/ROS/endoplasmic reticulum stress pathway. Scientific Reports. 2025, 15(1), 37485. DOI: 10.1038/s41598-025-21526-0

Cheng LY, Li HL, Xie CJ, Kuang KK, Wan BH, Chen PP, et al. Usenamine a, an RGS2 inhibitor, exerts anti-NSCLC activity and enhances cytotoxicity of gemcitabine by inducing ER stress and Notch1-mediated autophagy. Bioorganic Chemistry. 2025, 165, 109010. DOI: 10.1016/j.bioorg.2025.109010

Shahreza RM, Zare H, Rastegar-Pouyani N, Aria H, Hakim F, Arefnia M, et al. GRP-based vaccines as a novel approach in cancer immunotherapy: mechanisms, challenges, and prospects. Cancer Cell International. 2025, 25(1), 338. DOI: 10.1186/s12935-025-03979-5

Wang H, Yi ZQ, Yan S, Wang YH, Zhang WS, Guo RQ, et al. Advances in ORMDL research in malignant tumors: a review. OncoTargets and Therapy. 2025, 18, 821-832. DOI: 10.2147/ott.s537194

Lv BX, Zhang DD. Targeting CREBRF in cancer: mechanistic insights and future directions. Biologics : Targets & Therapy. 2025, 19, 341-350. DOI: 10.2147/btt.s522325

Liu LH, Li S, Qu Y, Bai H, Pan XY, Wang J, et al. Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity. Cell Reports. Medicine. 2023, 4(10), 101206. DOI: 10.1016/j.xcrm.2023.101206

Liang SY, Jiaerheng G, Huang CJ, Xie YQ, Zou XN, Liang XF, et al. An endoplasmic reticulum‐targeting and calcium metabolism‐disrupting nanodrug enhances tumor photodynamic immunotherapy. Advanced Functional Materials. 2025, 35(32), 2424108. DOI: 10.1002/adfm.202424108

Markouli M, Strepkos D, Papavassiliou KA, Papavassiliou AG, Piperi C. Crosstalk of epigenetic and metabolic signaling underpinning glioblastoma pathogenesis. Cancers. 2022, 14(11), 2655. DOI: 10.3390/cancers14112655

Bhutia YD, Babu E, Ganapathy V. Re-programming tumour cell metabolism to treat cancer: No lone target for lonidamine. The Biochemical Journal. 2016, 473(11), 1503-1506. DOI: 10.1042/bcj20160068

Inoue M, Nakagawa Y, Azuma M, Akahane H, Chimori R, Mano Y, et al. The PKM2 inhibitor shikonin enhances piceatannol-induced apoptosis of glyoxalase I-dependent cancer cells. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 2024, 29(1), 52-62. DOI: 10.1111/gtc.13084

Wen MK, Yi N, Mijiti B, Zhao SH, Shen GQ. N6-methyladenosine (m6A) reader HNRNPA2B1 accelerates the cervical cancer cells aerobic glycolysis. Journal of Bioenergetics and Biomembranes. 2024, 56(6), 657-668. DOI: 10.1007/s10863-024-10042-x

Ma YB, Wang W, Idowu MO, Oh U, Wang XY, Temkin SM, et al. Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: anti-tumor activity of BAY-876. Cancers. 2018, 11(1), 33. DOI: 10.3390/cancers11010033

Song M, Kim SH, Im CY, Hwang HJ. Recent development of small molecule glutaminase inhibitors. Current Topics in Medicinal Chemistry. 2018, 18(6), 432-443. DOI: 10.2174/1568026618666180525100830

Pilanc-kudlek P, Cyranowski S, Wojnicki K, Ochocka N, Grzybowski M, Stańczak P, et al. 160P novel arginase inhibitor alone and in combination with an immune check point inhibitor reduces tumour growth in murine experimental gliomas. Annals of Oncology. 2019, 30(11), xi56-xi57. DOI: 10.1093/annonc/mdz452.031

Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, et al. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treatment Reviews. 2022, 110, 102461. DOI: 10.1016/j.ctrv.2022.102461

Dean DJ, Falchook GS, Patel MR, Brenner AJ, Infante JR, Arkenau HT, et al. Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640. Journal Clinical Oncology. 2016, 34(15_suppl), 2512-2512. DOI: 10.1200/jco.2016.34.15_suppl.2512

Svensson RU, Parker SJ, Eichner LJ, Kolar MJ, Wallace M, Brun SN, et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nature Medicine. 2016, 22(10), 1108-1119. DOI: 10.1038/nm.4181

Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, et al. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nature Communications. 2019, 10(1), 3981. DOI: 10.1038/s41467-019-11662-3

Pujalte-Martin M, Belaïd A, Bost S, Kahi M, Peraldi P, Rouleau M, et al. Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759. Molecular Oncology. 2024, 18(7), 1719-1738. DOI: 10.1002/1878-0261.13583

Beloueche-Babari M, Wantuch S, Casals Galobart T, Koniordou M, Parkes HG, Arunan V, et al. MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Research. 2017, 77(21), 5913-5924. DOI: 10.1158/0008-5472.can-16-2686

Verma S, Maniyar R, Ko M, Budhu S, Serganova I, Zappasodi R, et al. 619 pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy. Journal Immunotherapy of Cancer. 2021, 9(Suppl 2), A649-A649. DOI: 10.1136/jitc-2021-sitc2021.619

Zhang YL, Wei JY, Xu JQ, Leong WS, Liu GN, Ji TJ, et al. Suppression of tumor energy supply by liposomal nanoparticle-mediated inhibition of aerobic glycolysis. ACS Applied Materials & Interfaces. 2018, 10(3), 2347-2353. DOI: 10.1021/acsami.7b16685

Ni C, Li J. Take metabolic heterogeneity into consideration when applying dietary interventions to cancer therapy: a review. Heliyon. 2023, 9(12), e22814. DOI: 10.1016/j.heliyon.2023.e22814

Clevenger AJ, McFarlin MK, Gorley JPM, Solberg SC, Madyastha AK, Raghavan SA. Advances in cancer mechanobiology: metastasis, mechanics, and materials. APL Bioengineering. 2024, 8(1), 011502. DOI: 10.1063/5.0186042

Zhou HY, Wang M, Zhang YX, Su QQ, Xie ZX, Chen XY, et al. Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis. Cancer Communications. 2022, 42(5), 374-400. DOI: 10.1002/cac2.12294

Kang S, Lee S, Park S. iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery. Polymers. 2020, 12(9), 1906. DOI: 10.3390/polym12091906

Tolaney SM, Boucher Y, Duda DG, Martin JD, Seano G, Ancukiewicz M, et al. Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients. Proceedings of the National Academy of Sciences of the United States of America. 2015, 112(46), 14325-14330. DOI: 10.1073/pnas.1518808112

Sun Y, Zhao W, Spriggs DR, Jain RK, Xu L. Abstract PR07: reprogramming the tumor microenvironment with losartan to enhance immunotherapy of ovarian cancer. Clinical Cancer Research. 2020, 26 (13_Supplement), PR07. DOI: 10.1158/1557-3265.ovca19-pr07

Chen M, Xie SB. Therapeutic targeting of cellular stress responses in cancer. Thoracic Cancer. 2018, 9(12), 1575-1582. DOI: 10.1111/1759-7714.12890

Onwudiwe K, Najera J, Siri S, Datta M. Do tumor mechanical stresses promote cancer immune escape? Cells. 2022, 11(23), 3840. DOI: 10.3390/cells11233840

Downloads

Published

2026-02-11

How to Cite

Qianqian Zhou, & Wang, J. (2026). Tumor Microenvironment Stress and Stress Adaptation Mechanisms. Journal of Cancer Biomoleculars and Therapeutics, 3(1), 57–77. Retrieved from https://jcbt.eternopublisher.com/index.php/jcbt/article/view/97